Skip to content
10-K

Annual Report

Aura Biosciences, Inc. AURA

0000950170-25-043943

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 19, 2025 50.23M sh
Shares Diluted FY 2024 · Dec 31, 2023 39.62M sh
Capex FY 2024 · Dec 31, 2023 $709K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$63.85M
Cash And Equivalents FY 2024 · Dec 31, 2023 $41.06M
Current Liabilities FY 2024 · Dec 31, 2023 $12.36M
Total Liabilities FY 2024 · Dec 31, 2023 $29.23M
Current Assets FY 2024 · Dec 31, 2023 $231.79M
Total Assets FY 2024 · Dec 31, 2023 $255.08M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.93
Eps Basic FY 2024 · Dec 31, 2023 −$1.93
Sga Expense FY 2024 · Dec 31, 2023 $19.76M
Rd Expense FY 2024 · Dec 31, 2023 $65.23M
Net Income FY 2024 · Dec 31, 2023 −$76.41M
Operating Income FY 2024 · Dec 31, 2023 −$84.99M
Stockholders Equity FY 2024 · Dec 31, 2022 $195.58M